1. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
- Author
-
Abdallah BM, Ditzel N, Mahmood A, Isa A, Traustadottir GA, Schilling AF, Ruiz-Hidalgo MJ, Laborda J, Amling M, and Kassem M
- Subjects
- Animals, Body Patterning, Body Weight, Bone Resorption blood, Bone and Bones abnormalities, Bone and Bones metabolism, Calcium-Binding Proteins, Cell Differentiation, Collagen Type I metabolism, Estrogens metabolism, Female, Gene Expression Regulation, Immunologic Factors genetics, Immunologic Factors metabolism, Intercellular Signaling Peptides and Proteins blood, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, NF-kappa B metabolism, Organ Size, Osteoblasts metabolism, Osteoblasts pathology, Ovariectomy, Phenotype, Signal Transduction, T-Lymphocytes metabolism, Bone Resorption metabolism, Bone Resorption pathology, Bone and Bones pathology, Estrogens deficiency, Intercellular Signaling Peptides and Proteins metabolism
- Abstract
Delta-like 1/fetal antigen 1 (DLK1/FA-1) is a transmembrane protein belonging to the Notch/Delta family that acts as a membrane-associated or a soluble protein to regulate regeneration of a number of adult tissues. Here we examined the role of DLK1/FA-1 in bone biology using osteoblast-specific Dlk1-overexpressing mice (Col1-Dlk1). Col1-Dlk1 mice displayed growth retardation and significantly reduced total body weight and bone mineral density (BMD). Micro-computed tomographis (µCT) scanning revealed a reduced trabecular and cortical bone volume fraction. Tissue-level histomorphometric analysis demonstrated decreased bone-formation rate and enhanced bone resorption in Col1-Dlk1 mice compared with wild-type mice. At a cellular level, Dlk1 markedly reduced the total number of bone marrow (BM)-derived colony-forming units fibroblasts (CFU-Fs), as well as their osteogenic capacity. In a number of in vitro culture systems, Dlk1 stimulated osteoclastogenesis indirectly through osteoblast-dependent increased production of proinflammatory bone-resorbing cytokines (eg, Il7, Tnfa, and Ccl3). We found that ovariectomy (ovx)-induced bone loss was associated with increased production of Dlk1 in the bone marrow by activated T cells. Interestingly, Dlk1(-/-) mice were significantly protected from ovx-induced bone loss compared with wild-type mice. Thus we identified Dlk1 as a novel regulator of bone mass that functions to inhibit bone formation and to stimulate bone resorption. Increasing DLK1 production by T cells under estrogen deficiency suggests its possible use as a therapeutic target for preventing postmenopausal bone loss., (Copyright © 2011 American Society for Bone and Mineral Research.)
- Published
- 2011
- Full Text
- View/download PDF